

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Colorectal neoplasms | D015179 | — | — | 1 | — | — | — | — | 1 |
| Squamous cell carcinoma of head and neck | D000077195 | — | — | 1 | — | — | — | — | 1 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 1 | — | — | — | — | 1 |
| Glandular and epithelial neoplasms | D009375 | — | — | 1 | — | — | — | — | 1 |
| Myoepithelioma | D009208 | — | — | 1 | — | — | — | — | 1 |
| Drug common name | ENADENOTUCIREV |
| INN | enadenotucirev |
| Description | Enadenotucirev is an investigational oncolytic virus that is in clinical trials for various cancers.
|
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | — |
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL4297746 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | KX7ZYR6OQW (ChemIDplus, GSRS) |
